Nahum Ari, Drekonja Dimitri M, Alpern Jonathan D
Department of Medicine, HealthPartners, Minneapolis, Minnesota, USA.
Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Open Forum Infect Dis. 2021 Jan 4;8(2):ofaa657. doi: 10.1093/ofid/ofaa657. eCollection 2021 Feb.
As states and health systems prepare to deliver severe acute respiratory syndrome coronavirus 2 vaccines to the American public, a confluence of factors has the potential to interfere with these efforts: misinformation about coronavirus disease 2019, vaccine hesitancy, and the erosion of the American public's trust in the vaccine regulatory process due to recent and ongoing events. Broad action is needed to address these issues, including improved and consistent communication by the Food and Drug Administration, restoration of the Centers for Disease Control as an independent and science-driven institution, and more aggressive policies to counteract misinformation, particularly on social media platforms.
随着各州和卫生系统准备向美国公众提供严重急性呼吸综合征冠状病毒2疫苗,多种因素可能会干扰这些努力:关于2019冠状病毒病的错误信息、疫苗犹豫,以及近期和持续发生的事件导致美国公众对疫苗监管程序的信任受到侵蚀。需要采取广泛行动来解决这些问题,包括美国食品药品监督管理局加强并保持一致的沟通、恢复疾病控制中心作为一个独立的、以科学为驱动的机构,以及采取更积极的政策来对抗错误信息,尤其是在社交媒体平台上的错误信息。